Reuters logo
BRIEF-Aldeyra Therapeutics announces positive results from dry eye disease phase 2a clinical trial
2017年9月12日 / 上午11点18分 / 14 天前

BRIEF-Aldeyra Therapeutics announces positive results from dry eye disease phase 2a clinical trial

Sept 12 (Reuters) - Aldeyra Therapeutics Inc:

* Aldeyra Therapeutics announces positive results from dry eye disease phase 2a clinical trial

* Aldeyra Therapeutics says statistically and clinically significant improvement across multiple sign and symptom endpoints for ADX-102

* Aldeyra Therapeutics says no safety concerns observed for any of the formulations of ADX-102, no serious adverse events were reported

* Aldeyra Therapeutics says look forward to initiation of phase 2b clinical trial in dry eye disease in H1 of 2018 Source text for Eikon: Further company coverage:

我们的标准汤森路透“信任原则”
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below